Pfizer CEO says he welcomes good ideas as Starboard ups pressure on company

In a Tuesday interview with CNBC's Jim Cramer, Pfizer CEO Albert Bourla struck a positive tone about activist investor Starboard Value, saying he agreed with some of its criticisms, but maintained that the company is headed in a good direction. "I agree that the total shareholder return right now is very poor. Why is that? Because we had a significant drop last year," he said. "I think we are doing a lot of changes. But if Starboard, and anybody else for that matter, have good ideas, I will certainly discus ...